Yesterday, Dr. Céline Gounder and I caught up on a handful of issues in medicine and public health that we’ve been tracking closely. As always, Dr. Gounder brought data-driven insights from her expertise as a physician, journalist, and public health professional. We covered everything from the end of the government shutdown to some new studies that caught our eye, ranging from pregnancy and firearm-related homicide to caffeine and heart rhythms. I hope you find the session informative and enjoyable. Personally, I always have a great time chatting with Céline, and I always learn a lot in the process!
Closed captions (㏄) for the above video and a transcript option (📄) can be found beneath the video playback control bar above. A summary with timecodes can be found below.
Doctor’s Lounge — Inside Medicine Q&A Summary
(Summary aided by ChatGPT).
Government shutdown, ACA subsidies, and the CR (0:30–06:00)
We walk through how the funding lapse happened and why it became a health-policy fight: enhanced ACA premium tax credits (pandemic-era boosts) are expiring amid rising premiums. The bipartisan stopgap vote funds agencies and ends furloughs with back pay, but only guarantees a separate December vote on the ACA subsidies. There’s no guarantee of an extension yet. Politically, both parties face risk; practically, millions could lose affordable coverage without renewal.
Shutdown tactics and federal workforce “RIFs” (08:24–09:21)
We flag reports that shutdown conditions were leveraged to justify another round of CDC/HHS reductions in force (RIFs)—legally dubious, because the RIFs appear to have been ad-hoc personnel purges rather than carefully justified programmatic cuts. Expect disputes and litigation.
“Should we run for office?”—why policy ≠ campaigning (09:31–12:17)
We discuss why neither of us plans to run for office: invasive scrutiny, fundraising grind, and congressional dysfunction that delays impact for junior members. We both prefer to influence policy directly and support candidates who can do the electoral work.
FDA, menopause hormone therapy, and the black-box reversal (12:36–19:05)
We outline why lifting the boxed warning makes sense given re-analyses of Women’s Health Initiative data: the small signal of increases in cancer was tied to older regimens; there was no increase in breast-cancer mortality; and starting hormonal therapy before age 60 (or within 10 years of menopause) seems to improve the risk–benefit profile. Potential benefits include cardiovascular outcomes, fewer bone fractures, and possibly cognitive protection. We also note the communications challenge when good guidance comes out of an HHS that, in other areas, has spread misinformation.
“Fixing” the CDC: reform, hubris, and budgets (19:24–23:37)
We reflect on repeated promises to modernize CDC that run into fiefdoms, limited appropriations, and organizational inertia. Real change would alter the org chart and chain of command—something that President Trump’s recent budget proposals threatened for the wrong reasons.
Covid-19 in pregnancy and early neurodevelopmental diagnoses (24:01–28:21)
We review a Mass General cohort study (mostly capturing the pre-vaccine era): maternal SARS-CoV-2 infection correlated with slightly higher rates of early neurodevelopmental diagnoses by age 3, with the strongest association coming when infection occurred in the third trimester. The finding was also more pronounced in boys. Mechanisms could involve inflammation/cytokines and fever; we underscore treating high fevers in pregnancy.
We highlight a new umbrella review from the BMJ does not support an acetaminophen–autism link and reiterate that untreated fever is harmful in pregnancy. Invoking a “precautionary principle” that withholds fever control is backwards.
Timing boosters in pregnancy (28:41–29:37)
Because infection-prevention benefit from Covid-19 vaccines and boosters wanes, maximizing coverage in the third trimester of pregnancy may best protect infants via transplacental antibodies—aligning with the trimester-specific signal noted above.
Firearm homicide and pregnancy (31:11–36:10)
We discuss a JAMA Network Open study that founds an association between higher state-level firearm ownership and higher rates pregnancy-associated homicide, with Black women and women aged 20–24 at greatest risk. Importantly, in the U.S., pregnancy-associated homicide exceeds leading medical causes of maternal death—another dimension of America’s maternal-mortality problem.
Broader reproductive health access is eroding. Medicaid and pregnancy (36:13–37:26)
Beyond abortion, cuts at CDC, HRSA (Health Resources and Services Administration), and Title X-funded clinics threaten contraception access amid high rates of obesity, hypertension, and diabetes—factors that drive maternal morbidity and mortality. We remind viewers that roughly half of US births are covered by Medicaid (under various state brands). Program cuts ripple through prenatal, delivery, and postpartum care, and through Title X clinics that often provide primary care, not just pregnancy care.
Caffeine and atrial fibrillation—a surprising signal in a clinical trial (37:28–44:07)
A clinical trial (published in JAMA) of habitual coffee drinkers (~7–8 cups/week) randomized participants to continue or abstain from caffeine for six months. AFib recurrence was lower in the coffee group (47%) vs. abstinence (64%). This was a surprise. We discussed some caveats. Still, along with a prior trial published in The New England Journal of Medicine showing the relatively immediate effects of caffeine on heart rhythms (and sleep), it illustrates how wearables enable physiologic insights.
Closing thoughts (45:21–end)
We end where we started: a reminder that reproductive health access and funding cuts will quietly raise risk unless voters understand the stakes. Our job is to keep translating complex policy and new evidence so people can act. And our viewers/readers are key to this, by amplifying these messages.
